The reported studies were part of the EU funded NewMood study (New Molecules in Mood Disorders, Sixth Framework Program of the EU, LSHM-CT-2004–503474) approved by the local Ethics Committees (North Manchester Local Research Ethics Committee, Manchester, UK; Scientific and Research Ethics Committee of the Medical Research Council, Budapest, Hungary) and carried out in accordance with the Declaration of Helsinki. All participants provided written informed consent before participating in the study. All the relevant data are included in the paper and Supporting Information file (S2 File).
